Erschienen in:
Open Access
01.12.2018 | Review Article
Fertility outcome after treatment of retained products of conception: a systematic review
verfasst von:
Tjalina W. O. Hamerlynck, Dora Meyers, Hannelore Van der Veken, Jan Bosteels, Steven Weyers
Erschienen in:
Gynecological Surgery
|
Ausgabe 1/2018
Abstract
Background
Treatment of retained products of conception (RPOC) can be expectant, medical or operative. Surgical removal of RPOC may lead to intrauterine adhesions (IUA) and Asherman’s syndrome.
Objective
To evaluate how treatment options for RPOC affect future fertility by means of a systematic review.
Search strategy
MEDLINE, EMBASE, The Cochrane Library, and clinical trial registers were searched, and reference lists were scanned.
Selection criteria
Randomised controlled trials (RCT) comparing different treatment options for RPOC (conservative, medical or surgical treatment, including curettage and/or hysteroscopic techniques, with or without application of anti-adhesion therapy), in women of reproductive age, were eligible for inclusion.
Data collection and analysis
Reviewers independently performed data extraction and quality of evidence assessment. For dichotomous variables, results were presented as risk ratio (RR) with 95% CI.
Main results
Two studies were included. Nonsignificant differences were observed between the use of an anti-adhesion barrier gel versus no treatment after operative hysteroscopy in IUAs (RR 0.32, 95% CI 0.04 to 2.80, P value = 0.30) and clinical pregnancy (RR 2.22, 95% CI 0.67 to 7.42, P value = 0.19), and between hysteroscopic morcellation versus loop resection in IUAs (RR 0.86, 95% CI 0.06 to 13.12, P value = 0.91).
Conclusion
There is insufficient evidence on how different treatment options for RPOC affect future reproductive outcomes. Results from ongoing RCTs are needed to guide clinicians towards choosing the best treatment.